Healthcare Lilly's Deal Spree Is Eating Its Weight-Loss Windfall Revenue jumped 48% and full-year guidance rose again, but $2.8 billion in one quarter of deal write-offs is quietly trimming the world's biggest pharmaceutical cash machine.
